
Treace Med Concepts (TMCI) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Treace Med Concepts in August 2026.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
About This Stock
TREACE MED CONCEPTS INC
TMCI
Current Price
$4.60
Potential 12 Month Profit
96.98%
Sector
Healthcare
Industry
Healthcare Equipment & Supplies
Ticker
TMCI
Market Cap
$296.56M
Potential 12 Month Profit
96.98%
Sector
Healthcare
Industry
Healthcare Equipment & Supplies
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Treace Medical's stock, with a target price indicating slight growth potential.
Financial Health
TREACE MEDICAL CONCEPTS INC is performing well with strong profits, revenue, and cash flow.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.